Disclaimer: All information on this section is of a general nature.
Before making any investment decision, you should consult your adviser.
Investment Ideas - Integral Diagnostics (IDX)
Off the back of a disappointing FY16 which proved to be a tough market for the Australian diagnostic imaging industry, we believe that IDX looks set to improve as short term headwinds pass.
The IRESS consensus target price of $1.53 indicates some 24% upside potential relative to IDX’s current share price of $1.23. When added to an IRESS consensus dividend yield of ~6%, we calculate that IDX offers total potential upside of around 30%.
The IRESS consensus target price of $1.53 indicates some 24% upside potential relative to IDX’s current share price of $1.23. When added to an IRESS consensus dividend yield of ~6%, we calculate that IDX offers total potential upside of around 30%.